BMP-6 modulates somatostatin effects on luteinizing hormone production by gonadrotrope cells
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Grants-in-Aid for Scientific Research (24591364, 15K09434)
- Foundation for Growth Science and Astellas Foundation for Research on Metabolic Disorders
- Japan Foundation for Applied Enzymology
- The Uehara Memorial Foundation
This publication has 25 references indexed in Scilit:
- Interaction between gonadotropin-releasing hormone and bone morphogenetic protein-6 and -7 signaling in LβT2 gonadotrope cellsMolecular and Cellular Endocrinology, 2012
- BMP action in the pituitary: Its possible role in modulating somatostatin sensitivity in pituitary tumor cellsMolecular and Cellular Endocrinology, 2011
- Pituitary tumors: Cell type-specific roles for BMP-4Molecular and Cellular Endocrinology, 2010
- Involvement of bone morphogenetic protein-4 in GH regulation by octreotide and bromocriptine in rat pituitary GH3 cellsJournal of Endocrinology, 2008
- Effects of peroxisome proliferator-activated receptor activation on gonadotropin transcription and cell mitosis induced by bone morphogenetic proteins in mouse gonadotrope LβT2 cellsJournal of Endocrinology, 2007
- Bone Morphogenetic Protein-4 Control of Pituitary Pathophysiology2006
- Pituitary Development: Regulatory Codes in Mammalian OrganogenesisScience, 2002
- Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors.Journal of Clinical Investigation, 1997
- Intracellular calcium ion responses to somatostatin in cells from human somatotroph adenomasClinical Endocrinology, 1997
- Clinically nonfunctioning pituitary tumors are monoclonal in origin.Journal of Clinical Investigation, 1990